• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    3/31/23 11:46:10 AM ET
    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Finance: Consumer Services
    Finance
    Major Banks
    Finance
    Get the next $SNTG alert in real time by email

     

    On Friday, 93 stocks made new 52-week lows.

    Noteworthy Points From Today's 52-Week Lows:

    • Canopy Gwth (NASDAQ:CGC) was the largest, in terms of market cap, to set a new 52-week low.
    • Biodexa Pharmaceuticals (NASDAQ:BDRX) was the smallest company in terms of market cap to set a new 52-week low.
    • Ensysce Biosciences (NASDAQ:ENSC)'s stock moved significantly downwards, trading down 802.99% to reach a new 52-week low.
    • CXApp (NASDAQ:CXAI)'s stock bounced back the most, actually rising 0.01% after reaching its new 52-week low.

    On Friday, the following stocks broke to new 52-week lows:

    • Canopy Gwth (NASDAQ:CGC) stock hit a new 52-week low of $1.75. The stock was up 0.32% on the session.
    • Amerant Bancorp (NASDAQ:AMTB) stock hit a yearly low of $21.16. The stock was up 0.14% for the day.
    • Nikola (NASDAQ:NKLA) stock dropped to a yearly low on Friday of $1.15. Shares traded down 13.21%.
    • Great Southern Bancorp (NASDAQ:GSBC) shares set a new yearly low of $49.07 this morning. The stock was up 0.02% on the session.
    • Advantage Solutions (NASDAQ:ADV) stock set a new 52-week low of $1.56 on Friday, moving down 2.78%.
    • Heritage Commerce (NASDAQ:HTBK) shares set a new yearly low of $8.02 this morning. The stock was up 0.86% on the session.
    • Sharecare (NASDAQ:SHCR) shares hit a yearly low of $1.36. The stock was down 6.51% on the session.
    • First Community (NASDAQ:FCBC) stock achieved a new 52-week low on Friday morning, hitting $25.03 and moving up 0.36%.
    • Clover Health Investments (NASDAQ:CLOV) stock dropped to a yearly low on Friday of $0.82. Shares traded up 2.85%.
    • Tremor Intl (NASDAQ:TRMR) shares made a new 52-week low of $5.07 on Friday. The stock was up 0.39% for the day.
    • South Plains Financial (NASDAQ:SPFI) stock broke to a new 52-week low of $21.03 on Friday. Shares of the company traded up 1.13%.
    • Bank of Marin (NASDAQ:BMRC) stock hit a yearly low of $21.90. The stock was down 0.36% for the day.
    • Alerus Finl (NASDAQ:ALRS) stock hit a new 52-week low of $15.31. The stock was up 0.9% on the session.
    • Cano Health (NYSE:CANO) stock achieved a new 52-week low on Friday morning, hitting $0.76 and moving down 22.07%.
    • Kezar Life Sciences (NASDAQ:KZR) stock hit $3.12 on Friday morning, setting a new 52-week low for a change of up 2.37%.
    • Bankwell Finl Gr (NASDAQ:BWFG) stock hit a yearly low of $24.26. The stock was up 1.21% for the day.
    • Ocugen (NASDAQ:OCGN) stock achieved a new 52-week low on Friday morning, hitting $0.82 and moving up 3.72%.
    • Heron Therapeutics (NASDAQ:HRTX) stock hit a yearly low of $1.48. The stock was down 2.92% for the day.
    • YS Biopharma Co (NASDAQ:YS) shares moved down 9.31% on Friday to hit a new 52-week low of $1.82, drifting down 9.31%.
    • BP Prudhoe Bay (NYSE:BPT) shares were down 5.25% for the day, having made a 52-week low of $7.42.
    • Meta Materials (NASDAQ:MMAT) shares hit a yearly low of $0.41. The stock was up 1.56% on the session.
    • First Internet (NASDAQ:INBK) shares were up 0.66% for the day, having made a 52-week low of $16.35.
    • Investar Holding (NASDAQ:ISTR) shares fell to $13.89 on Friday, setting a new 52-week low with a shift of down 1.83%.
    • FLJ Group (NASDAQ:FLJ) stock drifted down 7.21% on Friday morning to hit a new 52-week low of $0.71.
    • Hanover Bancorp (NASDAQ:HNVR) shares reached a new 52-week low of $18.00 on Friday morning, moving up 0.82%.
    • Dragonfly Energy Hldgs (NASDAQ:DFLI) stock hit $2.54 on Friday morning, setting a new 52-week low for a change of down 4.46%.
    • Babylon Holdings (NYSE:BBLN) stock hit a yearly low of $4.61. The stock was up 0.41% for the day.
    • Arrival (NASDAQ:ARVL) stock set a new 52-week low of $0.13 on Friday, moving up 0.66%.
    • Veru (NASDAQ:VERU) shares were up 1.0% for the day, having made a 52-week low of $1.15.
    • Vinco Ventures (NASDAQ:BBIG) shares hit a yearly low of $0.31. The stock was up 0.28% on the session.
    • Finance of America (NYSE:FOA) stock hit $1.19 on Friday morning, setting a new 52-week low for a change of down 0.82%.
    • Virgin Orbit Holdings (NASDAQ:VORB) stock broke to a new 52-week low of $0.19 on Friday. Shares of the company traded down 40.75%.
    • Bioventus (NASDAQ:BVS) shares reached a new 52-week low of $0.80 on Friday morning, moving down 28.49%.
    • Enlivex Therapeutics (NASDAQ:ENLV) stock hit $3.36 on Friday morning, setting a new 52-week low for a change of up 1.72%.
    • JOANN (NASDAQ:JOAN) shares fell to $1.56 on Friday, setting a new 52-week low with a shift of down 7.1%.
    • Cyxtera Technologies (NASDAQ:CYXT) stock achieved a new 52-week low on Friday morning, hitting $0.34 and moving down 19.29%.
    • Jin Medical International (NASDAQ:ZJYL) shares set a new yearly low of $7.38 this morning. The stock was down 3.53% on the session.
    • Bed Bath & Beyond (NASDAQ:BBBY) stock hit a yearly low of $0.50. The stock was down 14.91% for the day.
    • Syros Pharmaceuticals (NASDAQ:SYRS) shares hit a yearly low of $2.61. The stock was down 3.31% on the session.
    • Advent Technologies Hldgs (NASDAQ:ADN) stock hit a yearly low of $0.94. The stock was down 15.38% for the day.
    • Praxis Precision Medicine (NASDAQ:PRAX) stock drifted up 1.42% on Friday morning to hit a new 52-week low of $0.79.
    • Chicken Soup for the Soul (NASDAQ:CSSE) stock hit a yearly low of $1.72. The stock was down 41.56% for the day.
    • HOOKIPA Pharma (NASDAQ:HOOK) stock broke to a new 52-week low of $0.70 on Friday. Shares of the company traded up 0.65%.
    • Fathom Digital Mfg (NYSE:FATH) shares hit a yearly low of $0.56. The stock was down 14.14% on the session.
    • Vicinity Motor (NASDAQ:VEV) shares moved down 10.04% on Friday to hit a new 52-week low of $0.70, drifting down 10.04%.
    • Chanson International (NASDAQ:CHSN) shares were up 0.81% for the day, having made a 52-week low of $1.86.
    • Checkpoint Therapeutics (NASDAQ:CKPT) shares made a new 52-week low of $1.85 on Friday. The stock was down 34.87% for the day.
    • SAB Biotherapeutics (NASDAQ:SABS) stock achieved a new 52-week low on Friday morning, hitting $0.40 and moving up 2.7%.
    • ICZOOM Group (NASDAQ:IZM) shares fell to $2.04 on Friday, setting a new 52-week low with a shift of down 5.48%.
    • CXApp (NASDAQ:CXAI) stock set a new 52-week low of $1.43 on Friday, moving up 0.01%.
    • SMX (Security Matters) (NASDAQ:SMX) stock dropped to a yearly low on Friday of $0.91. Shares traded down 2.11%.
    • Mangoceuticals (NASDAQ:MGRX) stock drifted down 7.59% on Friday morning to hit a new 52-week low of $1.28.
    • ENGlobal (NASDAQ:ENG) shares moved down 3.0% on Friday to hit a new 52-week low of $0.46, drifting down 3.0%.
    • Aeglea BioTherapeutics (NASDAQ:AGLE) shares moved down 0.21% on Friday to hit a new 52-week low of $0.28, drifting down 0.21%.
    • Lucy Scientific Discovery (NASDAQ:LSDI) stock drifted down 5.31% on Friday morning to hit a new 52-week low of $1.03.
    • Atlis Motor Vehicles (NASDAQ:AMV) shares set a new 52-week low of $0.55. The stock traded down 2.9%.
    • Asset Entities (NASDAQ:ASST) stock dropped to a yearly low on Friday of $1.37. Shares traded down 3.45%.
    • Shapeways Hldgs (NYSE:SHPW) stock hit a yearly low of $0.31. The stock was down 20.5% for the day.
    • Future FinTech Gr (NASDAQ:FTFT) stock hit a yearly low of $1.04. The stock was up 1.89% for the day.
    • Infinity Pharmaceuticals (NASDAQ:INFI) shares moved down 5.78% on Friday to hit a new 52-week low of $0.16, drifting down 5.78%.
    • AEterna Zentaris (NASDAQ:AEZS) stock set a new 52-week low of $2.49 on Friday, moving down 7.09%.
    • Aridis Pharmaceuticals (NASDAQ:ARDS) shares made a new 52-week low of $0.31 on Friday. The stock was down 6.5% for the day.
    • Akari Therapeutics (NASDAQ:AKTX) shares were up 3.47% for the day, having made a 52-week low of $0.14.
    • Nogin (NASDAQ:NOGN) shares set a new yearly low of $2.57 this morning. The stock was down 22.87% on the session.
    • Jaguar Health (NASDAQ:JAGX) shares fell to $0.65 on Friday, setting a new 52-week low with a shift of down 4.52%.
    • Bit Brother (NASDAQ:BTB) shares hit a yearly low of $0.83. The stock was down 22.03% on the session.
    • OceanPal (NASDAQ:OP) shares were down 3.02% for the day, having made a 52-week low of $0.34.
    • Aptinyx (NASDAQ:APTX) stock hit a yearly low of $0.12. The stock was down 6.37% for the day.
    • Biolase (NASDAQ:BIOL) shares fell to $0.27 on Friday, setting a new 52-week low with a shift of down 4.73%.
    • mCloud Technologies (NASDAQ:MCLD) shares were down 13.81% for the day, having made a 52-week low of $0.30.
    • ENDRA Life Sciences (NASDAQ:NDRA) shares reached a new 52-week low of $2.20 on Friday morning, moving down 12.31%.
    • Charah Solns (NYSE:CHRA) stock hit $2.03 on Friday morning, setting a new 52-week low for a change of down 19.77%.
    • Marker Therapeutics (NASDAQ:MRKR) shares set a new 52-week low of $0.74. The stock traded down 4.92%.
    • Netcapital (NASDAQ:NCPL) shares reached a new 52-week low of $0.95 on Friday morning, moving down 0.39%.
    • Aileron Therapeutics (NASDAQ:ALRN) shares moved down 0.76% on Friday to hit a new 52-week low of $1.24, drifting down 0.76%.
    • Gaucho Group Holdings (NASDAQ:VINO) stock dropped to a yearly low on Friday of $0.91. Shares traded down 3.12%.
    • Tivic Health Systems (NASDAQ:TIVC) stock drifted down 11.05% on Friday morning to hit a new 52-week low of $0.15.
    • Sentage Hldgs (NASDAQ:SNTG) shares were down 7.56% for the day, having made a 52-week low of $1.55.
    • BiondVax Pharmaceuticals (NASDAQ:BVXV) shares were down 3.74% for the day, having made a 52-week low of $2.03.
    • Harbor Custom Dev (NASDAQ:HCDI) stock hit a new 52-week low of $4.77. The stock was down 5.31% on the session.
    • SciSparc (NASDAQ:SPRC) shares hit a yearly low of $0.46. The stock was down 2.1% on the session.
    • Clearmind Medicine (NASDAQ:CMND) stock hit $1.17 on Friday morning, setting a new 52-week low for a change of down 5.42%.
    • Kiromic BioPharma (NASDAQ:KRBP) shares made a new 52-week low of $3.16 on Friday. The stock was up 3.63% for the day.
    • Mobiquity Technologies (NASDAQ:MOBQ) stock set a new 52-week low of $0.17 on Friday, moving down 4.28%.
    • ContraFect (NASDAQ:CFRX) stock dropped to a yearly low on Friday of $1.73. Shares traded down 17.3%.
    • Fresh Tracks Therapeutics (NASDAQ:FRTX) stock hit $0.66 on Friday morning, setting a new 52-week low for a change of down 3.64%.
    • G Medical Innovations (NASDAQ:GMVD) stock set a new 52-week low of $0.90 on Friday, moving down 42.96%.
    • Allarity Therapeutics (NASDAQ:ALLR) shares hit a yearly low of $1.65. The stock was down 5.68% on the session.
    • Biodexa Pharmaceuticals (NASDAQ:BDRX) shares reached a new 52-week low of $0.30 on Friday morning, moving down 25.47%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $SNTG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SNTG
    $SPFI
    $SPRC
    $SYRS

    CompanyDatePrice TargetRatingAnalyst
    Praxis Precision Medicines Inc.
    $PRAX
    2/24/2026$500.00Outperform
    Wolfe Research
    Bioventus Inc.
    $BVS
    2/9/2026$13.00Outperform
    Barrington Research
    Bankwell Financial Group Inc.
    $BWFG
    2/2/2026$48.00 → $49.00Market Perform
    Hovde Group
    Praxis Precision Medicines Inc.
    $PRAX
    2/2/2026$282.00Equal Weight
    Wells Fargo
    First Internet Bancorp
    $INBK
    1/30/2026$26.00 → $29.00Outperform
    Hovde Group
    South Plains Financial Inc.
    $SPFI
    1/27/2026$47.00 → $49.00Outperform
    Hovde Group
    Alerus Financial Corporation
    $ALRS
    1/7/2026Outperform → Market Perform
    Hovde Group
    Akari Therapeutics plc
    $AKTX
    1/5/2026$1.00Buy
    Ladenburg Thalmann
    More analyst ratings

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Fenech Joseph A. bought $19,830 worth of shares (1,000 units at $19.83), increasing direct ownership by 11% to 10,102 units (SEC Form 4)

    4 - First Internet Bancorp (0001562463) (Issuer)

    2/26/26 11:54:08 AM ET
    $INBK
    Major Banks
    Finance

    Amendment: Director Seidman Lawrence B bought $473,962 worth of shares (10,000 units at $47.40) (SEC Form 4)

    4/A - Bankwell Financial Group, Inc. (0001505732) (Issuer)

    2/26/26 9:58:58 AM ET
    $BWFG
    Major Banks
    Finance

    President/CEO Turner Joseph W gifted 1,200 shares, decreasing direct ownership by 0.87% to 136,182 units (SEC Form 4)

    4 - GREAT SOUTHERN BANCORP, INC. (0000854560) (Issuer)

    2/24/26 6:00:27 PM ET
    $GSBC
    Major Banks
    Finance

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZYNRELEF KIT issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug ZYNRELEF KIT (SUPPL-18) with active ingredient BUPIVACAINE; MELOXICAM has changed to 'Approval' on 11/21/2024. Application Category: NDA, Application Number: 211988, Application Classification: Labeling

    11/22/24 4:36:11 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for APONVIE issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug APONVIE (SUPPL-3) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 216457, Application Classification: Labeling

    3/11/24 4:38:31 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for CINVANTI issued to HERON THERAPS INC

    Submission status for HERON THERAPS INC's drug CINVANTI (SUPPL-15) with active ingredient APREPITANT has changed to 'Approval' on 03/05/2024. Application Category: NDA, Application Number: 209296, Application Classification: Labeling

    3/11/24 4:38:29 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wolfe Research initiated coverage on Praxis Precision Medicines with a new price target

    Wolfe Research initiated coverage of Praxis Precision Medicines with a rating of Outperform and set a new price target of $500.00

    2/24/26 7:55:37 AM ET
    $PRAX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Barrington Research initiated coverage on Bioventus with a new price target

    Barrington Research initiated coverage of Bioventus with a rating of Outperform and set a new price target of $13.00

    2/9/26 8:08:39 AM ET
    $BVS
    Medical/Dental Instruments
    Health Care

    Hovde Group reiterated coverage on Bankwell Financial Group with a new price target

    Hovde Group reiterated coverage of Bankwell Financial Group with a rating of Market Perform and set a new price target of $49.00 from $48.00 previously

    2/2/26 7:12:59 AM ET
    $BWFG
    Major Banks
    Finance

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Follow-Through Leaders: Production Ramps, AI Alliances, Balance Sheet Strength

    DENVER, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Markets reward momentum and trends may sustain when execution follows headlines. Several companies are now moving beyond announcements and into operational validation, positioning themselves for potential continued follow-through. From biomaterials scale-up to enterprise AI deployment and disciplined capital allocation, these names are building narratives that extend beyond a single news cycle. Kraig Biocraft Laboratories: From Strategy to Scale Activity has accelerated at Kraig Biocraft Laboratories (OTCQB:KBLB) following confirmation that its 2026 production plan has officially transitioned from roadmap to execution. The company has moved bio

    2/27/26 9:45:46 AM ET
    $ENSC
    $PLTR
    $RXT
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology

    Alerus Financial Corporation Declares Cash Dividend on Common Shares

    MINNEAPOLIS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Alerus Financial Corporation (NASDAQ:ALRS) announced that its board of directors declared a regular quarterly cash dividend of $0.21 per common share on February 25, 2026, a 5.00% increase over the dividend paid a year ago. The dividend is payable on April 10, 2026, to stockholders of record as of close of business on March 27, 2026. Current and historic dividend information, as well as quarterly financial statements, investor presentations, and earnings call transcripts are available online through Alerus' investor relations website at investors.alerus.com.  About Alerus Financial CorporationAlerus Financial Corporation (NASDAQ:ALRS) is a co

    2/26/26 4:30:00 PM ET
    $ALRS
    Major Banks
    Finance

    Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance

    Business Highlights: Generated full year 2025 Adjusted EBITDA profitability while growing membership by 38% and Insurance revenue by 41% year-over-yearAchieved industry-leading 2026 AEP growth of 53% year-over-year with strong returning member retentionExpect improving cohort economics powered by Clover Assistant to drive our first-ever full year of GAAP Net Income profitability in 2026 Financial Results: Full year 2025 Medicare Advantage membership of 113,803, up 38% year-over-yearFull year 2025 Total revenues of $1.9 billion, up 40% year-over-yearFull year 2025 GAAP Net loss of $86 million, Adjusted EBITDA of $22 million, and Adjusted Net Income of $20 million Full Year 2026 Gu

    2/26/26 4:05:00 PM ET
    $CLOV
    Medical Specialities
    Health Care

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    SEC Filings

    View All

    SEC Form 10-K filed by Clover Health Investments Corp.

    10-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)

    2/27/26 8:08:29 AM ET
    $CLOV
    Medical Specialities
    Health Care

    SEC Form EFFECT filed by Clearmind Medicine Inc.

    EFFECT - Clearmind Medicine Inc. (0001892500) (Filer)

    2/27/26 12:15:18 AM ET
    $CMND
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 424B3 filed by Finance of America Companies Inc.

    424B3 - Finance of America Companies Inc. (0001828937) (Filer)

    2/26/26 4:42:39 PM ET
    $FOA
    Finance: Consumer Services
    Finance

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Fenech Joseph A. bought $19,830 worth of shares (1,000 units at $19.83), increasing direct ownership by 11% to 10,102 units (SEC Form 4)

    4 - First Internet Bancorp (0001562463) (Issuer)

    2/26/26 11:54:08 AM ET
    $INBK
    Major Banks
    Finance

    Amendment: Director Seidman Lawrence B bought $473,962 worth of shares (10,000 units at $47.40) (SEC Form 4)

    4/A - Bankwell Financial Group, Inc. (0001505732) (Issuer)

    2/26/26 9:58:58 AM ET
    $BWFG
    Major Banks
    Finance

    Chief Financial Officer Pham Benjamin bought $115,095 worth of shares (14,114 units at $8.15) (SEC Form 4)

    4 - Strive, Inc. (0001920406) (Issuer)

    2/19/26 8:00:23 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Financials

    Live finance-specific insights

    View All

    Alerus Financial Corporation Declares Cash Dividend on Common Shares

    MINNEAPOLIS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Alerus Financial Corporation (NASDAQ:ALRS) announced that its board of directors declared a regular quarterly cash dividend of $0.21 per common share on February 25, 2026, a 5.00% increase over the dividend paid a year ago. The dividend is payable on April 10, 2026, to stockholders of record as of close of business on March 27, 2026. Current and historic dividend information, as well as quarterly financial statements, investor presentations, and earnings call transcripts are available online through Alerus' investor relations website at investors.alerus.com.  About Alerus Financial CorporationAlerus Financial Corporation (NASDAQ:ALRS) is a co

    2/26/26 4:30:00 PM ET
    $ALRS
    Major Banks
    Finance

    Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance

    Business Highlights: Generated full year 2025 Adjusted EBITDA profitability while growing membership by 38% and Insurance revenue by 41% year-over-yearAchieved industry-leading 2026 AEP growth of 53% year-over-year with strong returning member retentionExpect improving cohort economics powered by Clover Assistant to drive our first-ever full year of GAAP Net Income profitability in 2026 Financial Results: Full year 2025 Medicare Advantage membership of 113,803, up 38% year-over-yearFull year 2025 Total revenues of $1.9 billion, up 40% year-over-yearFull year 2025 GAAP Net loss of $86 million, Adjusted EBITDA of $22 million, and Adjusted Net Income of $20 million Full Year 2026 Gu

    2/26/26 4:05:00 PM ET
    $CLOV
    Medical Specialities
    Health Care

    Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results

    – ZYNRELEF® and APONVIE® Drive 65% Year-Over-Year Net Revenue Growth in Acute Care Franchise– Achieved $154.9 Million in 2025 Net Revenue– Issues Full-Year 2026 Net Revenue Guidance of $173 to $183 Million and Adjusted EBITDA of $10 to $20 Million CARY, N.C., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (NASDAQ:HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced financial results for the three and twelve months ended December 31, 2025, and highlighted recent corporate updates. "As demonstrated in today's release, we are entering 2026 with exceptional momentum. The fourth quarter delivered the strongest results in the history of He

    2/26/26 8:00:00 AM ET
    $HRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Financial Insight: Purchase at Clover Health Investments Corp. on Jun 20

    The recent insider purchase at Clover Health Investments Corp. by Director Garipalli Vivek on June 20, 2024, has caught the attention of investors. Director Garipalli Vivek bought $1,000,426 worth of shares, acquiring 877,567 units at $1.14 per share, as reported in SEC Form 4. This insider purchase stands out among recent insider transactions at Clover Health. Looking at the previous transactions, there have been instances of insiders covering exercise/tax liability by selling shares, resulting in a decrease in their direct ownership percentages. For example, Reynoso Jamie L., Priest Brady Patrick, Toy Andrew, Sharp Aric R, Soares Karen, Chief Technology Officer Wai Conrad, and CEO Reynoso

    6/20/24 6:36:05 PM ET
    $CLOV
    Medical Specialities
    Health Care

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Finance of America Companies Inc.

    SC 13D/A - Finance of America Companies Inc. (0001828937) (Subject)

    12/11/24 8:30:03 PM ET
    $FOA
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13D/A filed by Akari Therapeutics plc

    SC 13D/A - Akari Therapeutics Plc (0001541157) (Subject)

    12/6/24 4:00:28 PM ET
    $AKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by OceanPal Inc.

    SC 13D/A - OceanPal Inc. (0001869467) (Subject)

    12/2/24 4:18:52 PM ET
    $OP
    Marine Transportation
    Consumer Discretionary

    $SNTG
    $SPFI
    $SPRC
    $SYRS
    Leadership Updates

    Live Leadership Updates

    View All

    Akari Therapeutics Appoints Leading Cancer Biology and RNA Expert, Prafulla Gokhale, Ph.D., to Scientific Advisory Board

    TAMPA, Fla. and LONDON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel immuno-oncology payloads, today announced the appointment of Prafulla Gokhale, Ph.D., Director of the Experimental Therapeutics Core and the Lurie Family Imaging Center at Dana-Farber Cancer Institute, to its Scientific Advisory Board. "Dr. Gokhale's expertise in experimental therapeutics, RNA biology and translational oncology comes at a pivotal time as we advance AKTX-101 toward the clinic," commented Abizer Gaslightwala, President and CEO of Akari Therapeutics. "His proven track record to develop novel t

    2/26/26 9:10:00 AM ET
    $AKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Advantage Solutions Appoints Thomas Turner and Frank Yao to Board of Directors

    ST. LOUIS, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Advantage Solutions Inc. (NASDAQ:ADV) announced the appointments of Thomas Turner and Xiaofeng "Frank" Yao to its Board of Directors, effective as of February 20, 2026. About Thomas Turner Turner currently serves as Senior Managing Director at CVC Capital Partners (U.S.) Inc., where he has been a member of the Capital Markets team since September 2022. Prior to CVC, Turner held Managing Director roles at Apollo Global Management, Inc. and Bank of America Merrill Lynch, as well as earlier positions at Goldman Sachs and Deutsche Bank. He holds a B.A. from Cornell University and an M.B.A. from New York University's Stern School of Business. Abou

    2/25/26 8:00:00 AM ET
    $ADV
    Real Estate

    Akari Therapeutics Appoints Globally Recognized Expert in RNA Biology and Cancer Research, Olga Anczukow, Ph.D., to its Scientific Advisory Board

    TAMPA, Fla. and LONDON, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel immuno-oncology payloads, today announced the appointment of Olga Anczukow, Ph.D. to its Scientific Advisory Board (SAB). Abizer Gaslightwala, President and Chief Executive Officer of Akari Therapeutics commented, "Dr. Anczukow is a leading authority in RNA splicing and cancer biology, an area of growing importance for the development of next-generation therapeutics. Her scientific rigor, translational mindset, and experience advancing RNA-focused discoveries toward clinical relevance make her an outstandin

    2/23/26 8:50:00 AM ET
    $AKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care